Carol Ann Satler

Presidente presso Respira Therapeutics, Inc.

Health Technology

Consumer Services

Profilo

Carol Ann Satler is currently the President, Director, and Chief Medical Officer at Respira Therapeutics, Inc. She was previously the President and Chief Executive Officer at Indigo Pharmaceuticals, Inc. She holds a doctorate degree from Case Western Reserve University and an undergraduate degree from Wesleyan University.

Posizioni attive di Carol Ann Satler

Società	Posizione	Inizio
Respira Therapeutics, Inc. Respira Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Respira Therapeutics, Inc. engages in provision of pulmonary delivery of therapeutics for respiratory diseases. Its technology Dry Powder Inhaler (DPI), deliver dry powder drug products to the lung more effectively than other DPI technologies. The company was founded in 2010 and is headquartered in Albuquerque, NM.	Presidente	-

Tutte le posizioni attive di Carol Ann Satler

Precedenti posizioni note di Carol Ann Satler

Società	Posizione	Fine
Indigo Pharmaceuticals, Inc. Indigo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Indigo Pharmaceuticals, Inc. manufactures pharmaceutical products. It mainly focuses on the development of new treatments for cardiovascular diseases, such as peripheral arterial disease. The company was founded in 2007 and is headquartered in New York, NY.	Amministratore Delegato	-

Vedi nel dettaglio l'esperienza di Carol Ann Satler

Formazione di Carol Ann Satler

Case Western Reserve University	Doctorate Degree
Wesleyan University	Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Carol Ann Satler

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	2
Indigo Pharmaceuticals, Inc. Indigo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Indigo Pharmaceuticals, Inc. manufactures pharmaceutical products. It mainly focuses on the development of new treatments for cardiovascular diseases, such as peripheral arterial disease. The company was founded in 2007 and is headquartered in New York, NY.	Health Technology
Respira Therapeutics, Inc. Respira Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Respira Therapeutics, Inc. engages in provision of pulmonary delivery of therapeutics for respiratory diseases. Its technology Dry Powder Inhaler (DPI), deliver dry powder drug products to the lung more effectively than other DPI technologies. The company was founded in 2010 and is headquartered in Albuquerque, NM.	Health Technology